PerkinElmer's Q3 Sales Fall 9 Percent, Bringing Profits Along | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its third-quarter revenues declined around 9 percent and its profit tumbled 57 percent

The Waltham, Mass.-based life sciences company reported total revenues of $437.1 million for the three-month period ended Sept. 30, compared to revenues of $478.7 million for the third quarter of 2008. Currency translation had a negative impact of 2 percent for the quarter, while acquisitions had a positive impact of 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.